GC녹십자 국산 수두 백신, 30년 데이터로 안전성·효과 입증 – WHO 인증 획득
Berlin – A decades-long commitment to research and development has culminated in a significant validation for GC녹십자 (Green Cross Corporation), a South Korean pharmaceutical company. A comprehensive review of data spanning 30 years has confirmed the safety and efficacy of its domestically developed varicella (chickenpox) vaccine, MAV/06, in a study published in the prestigious international … Read more